Compass Pharma Upgrades Production Capabilities

CLIFTON, N.J.To provide contract pharmaceutical packaging services for certain high-potency pharmaceutical products, Compass Pharma Services LLC completed a capital investment project to upgrade its production capabilities to include ISO Class 8 (ISO 14644) specifications.
These capital improvements now allow us to provide cGMP contract packaging services for select potent pharmaceutical compounds such as enzymes, antibiotics, antifolates, antimetabolites and some hormones, said Tony Fenno, chief operating officer, Compass Pharma. Compass Pharma investments continue to position the company as a responsive contract pharmaceutical packaging partner for sophisticated, high-demand contract packaging services for the pharmaceutical industry.